Clinical Outcome Assessments Toolbox for Radiopharmaceuticals

For nearly 40 years, the U.S. National Cancer Institute (NCI) has funded health-related quality-of-life (HRQOL) and symptom management in oncology clinical trials as a method for including a cancer patient's experience during and after treatment. The NCI's planned scope for HRQOL, symptom...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunos, Charles A., Capala, Jacek, Dicker, Adam P., Movsas, Benjamin, Ivy, Susan Percy, Minasian, Lori M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795707/
https://www.ncbi.nlm.nih.gov/pubmed/31649885
http://dx.doi.org/10.3389/fonc.2019.01028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795707/
https://www.ncbi.nlm.nih.gov/pubmed/31649885
http://dx.doi.org/10.3389/fonc.2019.01028

Ejemplares similares